Source - SMW
Indivior PLC announced Thursday that its U.S. subsidiary, Indivior, filed patent infringement lawsuits against against Dr. Reddy's, Actavis, Par, Alvogen and Teva over their respective proposed generic versions of the company's Suboxone sublingual film product.  

Shaun Thaxter, CEO of Indivior, said: 'We believe this new patent is strong and we are asserting it in order to protect our intellectual property rig.' 


At 9:04am: (LON:INDV) Indivior Plc share price was +1.85p at 400.55p